NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

融合切片檢查的市場趨勢·市場佔有率·市場規模的預測 (2021-2028年):切片檢查途徑·終端用戶·各地區

Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End-use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region, And Segment Forecasts, 2021 - 2028

出版商 Grand View Research, Inc. 商品編碼 1026802
出版日期 內容資訊 英文 100 Pages
商品交期: 2-10個工作天內
價格
融合切片檢查的市場趨勢·市場佔有率·市場規模的預測 (2021-2028年):切片檢查途徑·終端用戶·各地區 Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End-use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region, And Segment Forecasts, 2021 - 2028
出版日期: 2021年08月31日內容資訊: 英文 100 Pages
簡介

全球融合切片檢查的市場規模在預測期間內預計將以11.6%的年複合成長率推移,到2028年達到11億1000萬美元的規模。

前列腺癌的盛行率增加,標的切片檢查的需求提升,多參數 MRI 在前列腺癌治療中的使用增加等要素推動在預測期間內市場的成長。

本報告提供全球融合切片檢查的市場調查,彙整市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,償付環境,市場規模的轉變·預測,切片檢查root end用戶·地區/主要國家等各種區分的明細,競爭環境,市場佔有率,主要企業簡介等資訊。

第1章 調查手法·調查範圍

第2章 摘要整理

第3章 市場可變因素·趨勢·展望

  • 市場預測
  • 普及·成長預測製圖
  • 價值鏈分析
  • 市場動態
  • 市場分析工具

第4章 按市場分析·預測:切片檢查途徑

  • 經直腸
  • 經會陰

第5章 市場分析·預測:各終端用戶

  • 醫院
  • 診斷中心
  • 門診病人診療中心

第6章 市場分析·預測:地區·各主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭情形

  • 主要企業·近幾年的發展·影響分析
  • 主要企業·競爭上的分類
  • 業者情勢
  • 公開企業
  • 非公開企業
目錄
Product Code: GVR-4-68038-844-2

Fusion Biopsy Market Growth & Trends:

The global fusion biopsy market size is estimated to reach USD 1.11 billion by 2028 registering a CAGR of 11.6%, according to a new report by Grand View Research, Inc. The increasing prevalence of prostate cancer, growing demand for targeted biopsy, and the rising utilization rate of multiparametric MRI in prostate cancer care are factors expected to drive the market during the forecast period.

High sensitivity and specificity of targeted MR/Ultrasound fusion biopsy in delineating prostate lesions compared to other traditional technologies such as TRUS biopsy, PSA test, or Digital Rectal Examination is expected to contribute to the market growth. The reliability and reproducibility of the fusion biopsy system in the diagnosis of aggressive tumors is expected to make it a standard tool in prostate biopsy.

An increasing number of radiologists gaining expertise in interpreting prostate MRI coupled with the implementation of standard image grading systems such as PI-RADS and Gleason score has increased the utilization rate of targeted MR/Ultrasound fusion biopsy systems.

The increasing number of government initiatives in terms of funding research, spreading awareness, and conducting mass screening programs related to prostate cancer are expected to play a crucial in the growth of the market. Some of the growth strategies adopted by market players include partnership, product launch, participation in trade events and conferences, and acquisitions to sustain in this highly competitive market.

Fusion Biopsy Market Report Highlights:

  • The transrectal segment held the largest market share in 2019, as it is the gold standard and commonly used method of prostate fusion biopsy
  • The transperineal segment is expected to grow at the fastest rate during the forecast period owing to the safety, diagnostic efficiency, and ability to access the ventral prostate areas
  • The hospital segment accounted for the largest revenue share in 2019 because of the factors such as increasing the procurement rate of MR/US targeted fusion biopsy systems in teaching hospitals
  • The diagnostics centers segment is expected to grow at a significant rate over the forecast period. Shorter wait times, cost efficiency, and developing reimbursement paradigm are the factors expected to drive the growth of this segment
  • North America held the largest market share in the market in 2019 and is anticipated to maintain its dominance over the forecast period
  • Asia Pacific is anticipated to witness a CAGR of 10.5% during the forecast period owing to factors such as growing awareness about the sensitivity and specificity of MRI/US targeted fusion biopsy systems among urologists especially in countries such as Japan, Australia, and China.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Biopsy route
    • 1.1.2. End-use
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Biopsy route outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Fusion Biopsy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of prostate cancer
      • 3.4.1.2. Technological advancements in fusion imaging modalities
      • 3.4.1.3. Increasing funds and investments by public and private sector
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High cost of fusion biopsy system
      • 3.4.2.2. Liquid biopsy system
  • 3.5. Fusion Biopsy Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major deals & strategic alliances analysis
    • 3.5.4. Market entry strategies
    • 3.5.5. Covid-19 Impact Analysis

Chapter 4. Fusion Biopsy Market: Biopsy Route Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Transrectal
    • 4.1.2. Transperineal
  • 4.2. Biopsy Route Market Share, 2020 & 2028
  • 4.3. Segment Dashboard
  • 4.4. Global Fusion Biopsy Market by Biopsy Route Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 4.5.1. Transrectal
      • 4.5.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 4.5.2. Transperineal
      • 4.5.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)

Chapter 5. Fusion Biopsy Market: End-use Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Hospitals
    • 5.1.2. Diagnostic centers
    • 5.1.3. Ambulatory care centers
  • 5.2. End-use, 2020 & 2028
  • 5.3. Segment Dashboard
  • 5.4. Fusion Biopsy Market By End Use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 5.5.1. Hospitals
      • 5.5.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 5.5.2. Diagnostic Centers
      • 5.5.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 5.5.3. Ambulatory Care Centers
      • 5.5.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)

Chapter 6. Fusion Biopsy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2020 & 2028
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2020
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East and Africa
  • 6.6. Market Size, & Forecasts and Trend Analysis, 2020 to 2028:
  • 6.7. North America
    • 6.7.1. U.S.
      • 6.7.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.7.2. Canada
      • 6.7.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
  • 6.8. Europe
    • 6.8.1. U.K.
      • 6.8.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.8.2. Germany
      • 6.8.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.8.3. France
      • 6.8.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.8.4. Italy
      • 6.8.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.8.5. Spain
      • 6.8.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.8.6. Switzerland
      • 6.8.6.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.8.7. Belgium
      • 6.8.7.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Japan
      • 6.9.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.9.2. China
      • 6.9.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.9.3. India
      • 6.9.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.9.4. South Korea
      • 6.9.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.9.5. Thailand
      • 6.9.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.9.6. Australia
      • 6.9.6.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
  • 6.10. Latin America
    • 6.10.1. Brazil
      • 6.10.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.10.2. Mexico
      • 6.10.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.10.3. Argentina
      • 6.10.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
  • 6.11. MEA
    • 6.11.1. South Africa
      • 6.11.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.11.2. Saudi Arabia
      • 6.11.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
    • 6.11.3. UAE
      • 6.11.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competitive Categorization
    • 7.2.1. Innovators
    • 7.2.2. Market leaders
    • 7.2.3. Emerging players
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2019
  • 7.4. Public Companies
    • 7.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 7.4.2. Company market share/ranking, by region
    • 7.4.3. Competitive dashboard analysis
      • 7.4.3.1. Market differentiators
      • 7.4.3.2. Synergy analysis: major deals and strategic alliances
  • 7.5. Private Companies
    • 7.5.1. List of key emerging companies/technology disruptors/innovators
    • 7.5.2. Funding outlook
    • 7.5.3. Regional network map
    • 7.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
    • 7.5.5. Supplier ranking
    • 7.5.6. Key company profiled
    • 7.5.7. Eigen
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Koninklijke Philips N.V.
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Hitachi, Ltd.
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. MedCom
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product benchmarking
      • 7.5.10.4. Strategic initiatives
    • 7.5.11. ESAOTE SPA
      • 7.5.11.1. Company overview
      • 7.5.11.2. Financial performance
      • 7.5.11.3. Product benchmarking
      • 7.5.11.4. Strategic initiatives
    • 7.5.12. KOELIS
      • 7.5.12.1. Company overview
      • 7.5.12.2. Financial performance
      • 7.5.12.3. Product benchmarking
      • 7.5.12.4. Strategic initiatives
    • 7.5.13. Focal Healthcare
      • 7.5.13.1. Company overview
      • 7.5.13.2. Financial performance
      • 7.5.13.3. Product benchmarking
      • 7.5.13.4. Strategic initiatives
    • 7.5.14. GeoScan Medical
      • 7.5.14.1. Company overview
      • 7.5.14.2. Financial performance
      • 7.5.14.3. Product benchmarking
      • 7.5.14.4. Strategic initiatives
    • 7.5.15. UC-Care Medical Systems Ltd.
      • 7.5.15.1. Company overview
      • 7.5.15.2. Financial performance
      • 7.5.15.3. Product benchmarking
      • 7.5.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America fusion biopsy market, by region, 2016 - 2028 (USD Million)
  • Table 3 North America fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 4 North America fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 5 U.S. fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 6 U.S. fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 7 Canada fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 8 Canada fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 9 Europe fusion biopsy market, by region, 2016 - 2028 (USD Million)
  • Table 10 Europe fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 11 Europe fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 12 U.K. fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 13 U.K. fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 14 Germany fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 15 Germany fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 16 Italy fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 17 Italy fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 18 France fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 19 France fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 20 Spain fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 21 Spain fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 22 Switzerland fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 23 Switzerland fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 24 Belgium fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 25 Belgium fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 26 Asia Pacific fusion biopsy market, by region, 2016 - 2028 (USD Million)
  • Table 27 Asia Pacific fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 28 Asia Pacific fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 29 Japan fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 30 Japan fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 31 India fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 32 India fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 33 China fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 34 China fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 35 Thailand fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 36 Thailand fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 37 South Korea fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 38 South Korea fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 39 Australia fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 40 Australia fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 41 Latin America fusion biopsy market, by region, 2016 - 2028 (USD Million)
  • Table 42 Latin America fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 43 Latin America fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 44 Brazil fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 45 Brazil fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 46 Mexico fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 47 Mexico fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 48 Argentina fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 49 Argentina fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 50 MEA fusion biopsy market, by region, 2016 - 2028 (USD Million)
  • Table 51 MEA fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 52 MEA fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 53 South Africa fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 54 South Africa fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 55 Saudi Arabia fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 56 Saudi Arabia fusion biopsy market, by end use, 2016 - 2028 (USD Million)
  • Table 57 UAE fusion biopsy market, by biopsy route, 2016 - 2028 (USD Million)
  • Table 58 UAE fusion biopsy market, by end use, 2016 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Fusion biopsy market: market outlook
  • Fig. 14 Fusion biopsy market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Fusion biopsy market driver impact
  • Fig. 20 Fusion biopsy market restraint impact
  • Fig. 21 Fusion biopsy market strategic initiatives analysis
  • Fig. 22 Fusion biopsy market: biopsy route movement analysis
  • Fig. 23 Fusion biopsy market: biopsy route outlook and key takeaways
  • Fig. 24 Transrectal market estimates and forecast, 2016 - 2028
  • Fig. 25 Transperineal market estimates and forecast, 2016 - 2028
  • Fig. 26 Fusion biopsy market: end-use movement analysis
  • Fig. 27 Fusion biopsy market: end-use outlook and key takeaways
  • Fig. 28 Hospitals market estimates and forecast, 2016 - 2028
  • Fig. 29 Diagnostic centers market estimates and forecast, 2016 - 2028
  • Fig. 30 Ambulatory care centers market estimates and forecast, 2016 - 2028
  • Fig. 31 Fusion biopsy market: regional movement analysis
  • Fig. 32 Fusion biopsy market: regional outlook and key takeaways
  • Fig. 33 Fusion biopsy market share and leading players
  • Fig. 34 North America market share and leading players
  • Fig. 35 Europe market share and leading players
  • Fig. 36 Asia Pacific market share and leading players
  • Fig. 37 Latin America market share and leading players
  • Fig. 38 Middle East & Africa market share and leading players
  • Fig. 39 North America: SWOT
  • Fig. 40 Europe SWOT
  • Fig. 41 Asia Pacific SWOT
  • Fig. 42 Latin America SWOT
  • Fig. 43 MEA SWOT
  • Fig. 44 North America, by country
  • Fig. 45 North America
  • Fig. 46 North America market estimates and forecast, 2016 - 2028
  • Fig. 47 U.S.
  • Fig. 48 U.S. market estimates and forecast, 2016 - 2028
  • Fig. 49 Canada
  • Fig. 50 Canada market estimates and forecast, 2016 - 2028
  • Fig. 51 Europe
  • Fig. 52 Europe market estimates and forecast, 2016 - 2028
  • Fig. 53 U.K.
  • Fig. 54 U.K. market estimates and forecast, 2016 - 2028
  • Fig. 55 Germany
  • Fig. 56 Germany market estimates and forecast, 2016 - 2028
  • Fig. 57 France
  • Fig. 58 France market estimates and forecast, 2016 - 2028
  • Fig. 59 Italy
  • Fig. 60 Italy market estimates and forecast, 2016 - 2028
  • Fig. 61 Spain
  • Fig. 62 Spain market estimates and forecast, 2016 - 2028
  • Fig. 63 Switzerland
  • Fig. 64 Switzerland market estimates and forecast, 2016 - 2028
  • Fig. 65 Belgium
  • Fig. 66 Belgium market estimates and forecast, 2016 - 2028
  • Fig. 67 Asia Pacific
  • Fig. 68 Asia Pacific market estimates and forecast, 2016 - 2028
  • Fig. 69 China
  • Fig. 70 China market estimates and forecast, 2016 - 2028
  • Fig. 71 Japan
  • Fig. 72 Japan market estimates and forecast, 2016 - 2028
  • Fig. 73 India
  • Fig. 74 India market estimates and forecast, 2016 - 2028
  • Fig. 75 Thailand
  • Fig. 76 Thailand market estimates and forecast, 2016 - 2028
  • Fig. 77 South Korea
  • Fig. 78 South Korea market estimates and forecast, 2016 - 2028
  • Fig. 79 Australia
  • Fig. 80 Australia market estimates and forecast, 2016 - 2028
  • Fig. 81 Latin America
  • Fig. 82 Latin America market estimates and forecast, 2016 - 2028
  • Fig. 83 Brazil
  • Fig. 84 Brazil market estimates and forecast, 2016 - 2028
  • Fig. 85 Mexico
  • Fig. 86 Mexico market estimates and forecast, 2016 - 2028
  • Fig. 87 Argentina
  • Fig. 88 Argentina market estimates and forecast, 2016 - 2028
  • Fig. 89 Middle East and Africa
  • Fig. 90 Middle East and Africa. market estimates and forecast, 2016 - 2028
  • Fig. 91 South Africa
  • Fig. 92 South Africa market estimates and forecast, 2016 - 2028
  • Fig. 93 Saudi Arabia
  • Fig. 94 Saudi Arabia market estimates and forecast, 2016 - 2028
  • Fig. 95 UAE
  • Fig. 96 UAE market estimates and forecast, 2016 - 2028
  • Fig. 97 Participant categorization- fusion biopsy market
  • Fig. 98 Market share of key market players- fusion biopsy market